Navigation Links
Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
Date:1/3/2008

CRANBURY, N.J., Jan. 2 /PRNewswire-FirstCall/ -- Amicus Therapeutics Inc. (Nasdaq: FOLD), today announced that John F. Crowley, President and Chief Executive Officer, will present a corporate update at the 26th Annual JPMorgan Healthcare Conference in San Francisco, CA on Monday, January 7, 2008 at 11:30 am (Pacific Standard Time) at the Westin St. Francis Hotel.

The presentation will be webcast live and may be accessed by visiting Amicus' website at http://www.amicustherapeutics.com. A replay of the webcast will also be available on the Company's website until January 22, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease. The Company has completed Phase 1 clinical trials of AT2220 for the treatment of Pompe disease.

Forward-Looking Statements

Amicus cautions you that statements included in this press release that are not a description of historical facts are "forward-looking statements" within the meaning of Section 21E of the Private Securities Litigation Reform Act of
'/>"/>

SOURCE Amicus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Ironshore Pharmaceuticals & Development, Inc. ("Ironshore") ... company specializing in personalized medicine, to participate in ... to evaluate the safety and efficacy of HLD-200, ... disorder (ADHD). This is Restore,s second clinical trial ... partnered with Ironshore in 2014 and continues to ...
(Date:8/3/2015)... JORDAN, Utah , Aug. 3, 2015  BC Technical, ... has acquired Ohio Valley Medical Systems, one of the ... systems.  The addition of Ohio Valley Medical Systems allows ... now include Hitachi MRI.   "We couldn,t ... Alvarez , President and CEO of BC Technical. "The ...
(Date:8/3/2015)... AUSTIN, Texas, Aug. 3, 2015  Luminex Corporation (NASDAQ: ... second quarter ended June 30, 2015.  Financial and operating ... , Increased second quarter 2015 revenue by 6 percent ... , Grew second quarter 2015 assay revenue by ... second quarter of 2014. , Increased Q2 2015 ...
Breaking Medicine Technology:Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2BC Technical Acquires Ohio Valley Medical Systems 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16
(Date:8/4/2015)... ... 2015 , ... One of the nation’s leading experts in chronic pain management ... Pain Antidote , which provides strategies for people who suffer from chronic pain. ... Program, wrote the book in conjunction with Katherine Ketcham, an author who specializes in ...
(Date:8/4/2015)... Orange County, CA (PRWEB) , ... August 04, 2015 , ... ... services throughout Orange County, Los Angeles, Riverside, and San Bernardino, today announced that the ... stars. Two stars indicate that 24/7 Care At Home’s agency is well on the ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... information, checking with “Dr. Google” before calling a physician. In an effort to ... the first health care provider in Pennsylvania to publicly share patient satisfaction ratings ...
(Date:8/4/2015)... Missouri (PRWEB) , ... August 04, 2015 , ... ... (IAT) solutions, today announced that Bruce McCalley joins its executive leadership team as ... record of sales success at technology companies and expanding global markets with a ...
(Date:8/4/2015)... ... 2015 , ... Montclair State University and Atlantic Health System have launched a ... New Jersey, which starting this Fall will help prepare those entering this burgeoning, hybrid ... Health System, one of the largest health care organizations in New Jersey, to design ...
Breaking Medicine News(10 mins):Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 2Health News:Medical Expert's New Book Offers Help for Chronic Pain Sufferers 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3
... up delivery of anti-clotting drugs to stroke victims could greatly ... are the only effective treatment in the hours after a ... before brain cells die. The current standard requires that treatment ... and most patients who make it to the hospital on ...
... using information taken from a monkey gene ``dramatically protected'' ... experiment. The researchers believe the substance, which they ... but was lost to humans because of an ancient ... of California, Los Angeles, medical school, said he and ...
... should take as much care of your hair as you do ... explains that the outer layer of the hair - the cuticle ... lifeless, dry and faded.// Hair damage occurs from a range of ... sun exposure. Ideally, you'd pay as much attention to your hair ...
... may help to make people smarter by improving memory and ... to recall remembered words improved by 42% among people who ... Newcastle upon Tyne, are working on two theories. ... causes more oxygen and nutrients to be pumped into the ...
... who experience nausea may be suffering from anxiety or ... that should be investigated before aggressive treatments are begun// ... long-term use of potentially harmful medications for nausea, unnecessary ... for the patients. ,Haug and colleagues in the ...
... periodontal disease than non-diabetic pregnant women, according to a ... the University of Iowa Colleges of Dentistry and Medicine ... in their 20-39th week of pregnancy to examine the ... They found the diabetics flaunted more gingival inflammation and ...
Cached Medicine News:Health News:Scientists found ancient Human Germ Killer 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: